Follow The Filings

LEXX Lexaria Bioscience

Lexaria Bioscience earnings company data as of 4:49 AM ET 10/23

Limited consensus data for this ticker (thin coverage or data-plan limits). Dates may be company-announced rather than sell-side consensus. Calendar and recent prints remain the primary lens when available.

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 25 Nov EPS — — —
Rev — — —

Insider trades

Open-market buys and sales by LEXX's executives, directors and 10% owners in the last 12 months, from their Form 4s

All LEXX insider trades
  • None no insider bought on the open market
  • None no sales outside a trading plan
  • None no planned (10b5-1) sales

No open-market buys or sales on file.

Also filed in the last 12 months, not counted as buying or selling: 1 gift.

SEC filings

Recent issuer filings from EDGAR, 25 shown.

Filed Form Detail Links
424B3 424 B3
8-K 1.01,3.02,7.01,9.01
8-K 8.01
8-K 8.01
8-K 3.01
8-K 3.03,5.03,9.01
10-Q FORM 10-Q
10-Q FORM 10-Q
8-K 3.01
8-K 5.07
424B3
10-Q FORM 10-Q
424B5
8-K 1.01,3.02,8.01,9.01
DEF 14A FORM DEF 14A
424B3
S-1/A FORM S-1/A
10-K FORM 10-Q
S-1 FORM S-1
424B5
8-K 1.01,3.02,8.01,9.01
8-K 1.02
10-Q FORM 10-Q
8-K 1.01
8-K 1.01,3.02,8.01,9.01

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.